Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Acquisition of a Beckman Biomek i7 Automated Workstation for High-Throughput Screening Core Facility

Award Number: S15OD042581
ORGANIZATION: OFFICE OF THE DIRECTOR, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2027

Group Awards By:

View Award Description

Acquisition of a Beckman Biomek i7 Automated Workstation for High-Throughput Screening Core Facility - Project Summary The Center for Chemical Genomics (CCG) located within the Life Sciences Institute (LSI) serves as the high-throughput screening (HTS) core facility at the University of Michigan (U-M), available to all U-M faculty, as well as researchers external to U-M. The CCG is a critical component of both basic research and the early- phase drug discovery pipeline at U-M. It conducts ~20 HTS campaigns annually, in addition to supporting ~3-5 structure-activity relationship (SAR) campaigns. An automated liquid handler is used to support 100% of the screening experiments performed by the CCG, making it an integral part of the CCG’s workflow. The need for sterility while conducting HTS campaigns has conventionally been low, as the cell lines used in screens have been genetically engineered to be resistant to microbial contamination. However, the experimental protocols that the CCG aims to support are rapidly evolving. Increasingly, experiments demand the use of patient-derived cells for optimum physiological relevance, and the use of multi-day compound treatment protocols is also becoming more prevalent. In these experimental paradigms, a HEPA-filtered environment is critical to improving the reproducibility of experiments, increasing assay fidelity, and lowering the risk of cell infection and contamination. Cell contamination wastes reagents and leads to costly delays for both the CCG and its researchers. The CCG currently uses a Biomek FXP for its liquid handling needs. It is not possible to upgrade this instrument with the necessary HEPA-filtered enclosure attachment needed for sterility. As a result, the current equipment in the CCG cannot accommodate screening experiments that necessitate a sterile environment. The CCG requests funds to purchase the Beckman Biomek i7 outfitted with a HEPA-filtered hood, which will allow the CCG to perform automated high-throughput cell handling to support cell-based screening campaigns in a sterile environment. The CCG supports projects for U-M researchers and external collaborators across an incredible breadth of research fields, including research on cancer, cardiomyopathy, drug metabolism, diabetes and other metabolic disorders, ataxia, epilepsy, and many other diseases. The university has been a national leader in academic drug discovery for decades, demonstrated by several FDA approved drugs, as well as 16 drugs in current clinical development. The initial identification of bioactive lead molecules is a vital part of this pipeline and aligns with the mission of the NIH and U-M’s overarching goal of improving public health. Expanding the CCG’s capabilities to include a HEPA-filtered liquid handling environment will allow the CCG to support the next generation of HTS experiments, especially those with an emphasis on using patient-derived samples, ultimately improving the translational fidelity of our research as well as enabling U-M to support the development of more personalized medical approaches.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $348,594 )
2026	2026	REGENTS OF THE UNIVERSITY OF MICHIGAN	1109 GEDDES AVE STE 3300	ANN ARBOR	MI	48109	WASHTENAW	USA	Research Infrastructure Programs	000	1	8/18/2026	NEW	$348,594
														Subtotal = $348,594

Grand Total All Awards = $348,594

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Acquisition of a Beckman Biomek i7 Automated Workstation for High-Throughput Screening Core Facility

Award Number: S15OD042581

ORGANIZATION: OFFICE OF THE DIRECTOR, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer